Latest news
25 items- SECSEC Form 15-12G filed by Amedisys Inc15-12G - AMEDISYS INC (0000896262) (Filer)
- PRTwilio Set to Join S&P MidCap 400NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE:TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE:UNH) acquired Amedisys in a deal completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector August 19, 2025 S&P MidCap 400 Addition Twilio TWLO Information Technology August 19, 2025 S&P MidCap 400 Deletion Amedisys AMED Health Care For more information about S&P Dow Jones Indices, please visit www.spdji
- SECSEC Form S-8 POS filed by Amedisys IncS-8 POS - AMEDISYS INC (0000896262) (Filer)
- SECSEC Form S-8 POS filed by Amedisys IncS-8 POS - AMEDISYS INC (0000896262) (Filer)
- SECSEC Form S-8 POS filed by Amedisys IncS-8 POS - AMEDISYS INC (0000896262) (Filer)
- SECSEC Form S-8 POS filed by Amedisys IncS-8 POS - AMEDISYS INC (0000896262) (Filer)
- SECSEC Form S-8 POS filed by Amedisys IncS-8 POS - AMEDISYS INC (0000896262) (Filer)
- SECSEC Form S-8 POS filed by Amedisys IncS-8 POS - AMEDISYS INC (0000896262) (Filer)
- SECSEC Form S-8 POS filed by Amedisys IncS-8 POS - AMEDISYS INC (0000896262) (Filer)
- SECSEC Form S-8 POS filed by Amedisys IncS-8 POS - AMEDISYS INC (0000896262) (Filer)
- INSIDERChief Legal Officer Griffin Jennifer G returned 20,173 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - AMEDISYS INC (0000896262) (Issuer)
- INSIDERDirector Capps Vickie L returned 9,818 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - AMEDISYS INC (0000896262) (Issuer)
- INSIDERDirector Kline Teresa L. returned 9,818 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - AMEDISYS INC (0000896262) (Issuer)
- INSIDERChief Strategy Officer Muscato Nick returned 39,367 shares to the company and converted options into 3,468 shares, closing all direct ownership in the company (SEC Form 4)4 - AMEDISYS INC (0000896262) (Issuer)
- INSIDERDirector Rideout Jeffrey A returned 9,335 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - AMEDISYS INC (0000896262) (Issuer)
- INSIDERDirector Kusserow Paul B. K. returned 439,745 shares to the company (SEC Form 4)4 - AMEDISYS INC (0000896262) (Issuer)
- INSIDERDirector Klapstein Julie D returned 16,031 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - AMEDISYS INC (0000896262) (Issuer)
- INSIDERDirector Coye Molly Joel returned 8,818 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - AMEDISYS INC (0000896262) (Issuer)
- SECAmedisys Inc filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Financial Statements and Exhibits8-K - AMEDISYS INC (0000896262) (Filer)
- SECSEC Form SCHEDULE 13G filed by Amedisys IncSCHEDULE 13G - AMEDISYS INC (0000896262) (Subject)
- INSIDERChief Accounting Officer Guidroz Allyson was granted 2,015 shares, increasing direct ownership by 27% to 9,472 units (SEC Form 4)4 - AMEDISYS INC (0000896262) (Issuer)
- SECSEC Form 8-K filed by Amedisys Inc8-K - AMEDISYS INC (0000896262) (Filer)
- SECSEC Form 10-Q filed by Amedisys Inc10-Q - AMEDISYS INC (0000896262) (Filer)
- SECAmedisys Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - AMEDISYS INC (0000896262) (Filer)
- INSIDERChief Accounting Officer Guidroz Allyson covered exercise/tax liability with 25 shares, decreasing direct ownership by 0.33% to 7,457 units (SEC Form 4)4 - AMEDISYS INC (0000896262) (Issuer)
AMED FAQ
6 questionsWhat does Amedisys Inc do?
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services...Where does AMED stock trade?
Amedisys Inc (AMED) is listed on NASDAQ.What sector and industry is AMED in?
Amedisys Inc operates in the Health Care sector, Medical/Nursing Services industry.What are analysts saying about AMED?
Amedisys Inc has had 8 recent analyst actions on file. The most recent action was from Deutsche Bank: Hold on 2024-07-29.What companies are similar to AMED?
Notable peers in the same industry include BTSG (BrightSpring Health Services Inc.), HIMS (Hims & Hers Health Inc.), CHE (Chemed Corp), LHCG (LHC Group), OPCH (Option Care Health Inc.). Compare AMED side-by-side with any of them on Quantisnow.How can I track AMED on Quantisnow?
Quantisnow aggregates Amedisys Inc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AMED to receive live email and push alerts on every new disclosure.